DNA N6-methyladenine demethylase ALKBH1 enhances osteogenic differentiation of human MSCs

Chenchen Zhou,Yuting Liu,Xiaobing Li,Jing Zou and Shujuan Zou

DNA N6-methyladenine demethylase ALKBH1 enhances osteogenic differentiation of human MSCs

Chenchen Zhou,Yuting Liu,Xiaobing Li,Jing Zou and Shujuan Zou

ALKBH1 was recently discovered as a demethylase for DNA N6-methyladenine(N6-mA),a new epigenetic modi f i cation,and interacts with the core transcriptional pluripotency network of embryonic stem cells. However,the role of ALKBH1 and DNA N6-mA in regulating osteogenic differentiation is largely unknown. In this study,we demonstrated that the expression of ALKBH1 in human mesenchymal stem cells(MSCs) was upregulated during osteogenic induction.Knockdown of ALKBH1 increased the genomic DNA N6-mA levels and signi f i cantly reduced the expression of osteogenic-related genes,alkaline phosphatase activity,and mineralization.ALKBH1-depleted MSCs also exhibited a restricted capacity for bone formation in vivo. By contrast,the ectopic overexpression of ALKBH1 enhanced osteoblastic differentiation.Mechanically, we found that the depletion of ALKBH1 resulted in the accumulation of N6-mA on the promoter region of ATF4,which subsequently silenced ATF4 transcription.In addition,restoring the expression of ATP by adenovirus-mediated transduction successfully rescued osteogenic differentiation.Taken together,our results demonstrate that ALKBH1 is indispensable for the osteogenic differentiation of MSCs and indicate that DNA N6-mA modi f i cations area new mechanism for the epigenetic regulation of stem cell differentiation.

INTRODUCTION

Stem cells are characterized by two features:the ability to differentiate into multiple cell types and the ability to selfrenew.1–2Mesenchymal stem cells(MSCs)are one type of postnatal stem cell with a pluripotent differentiation potential that is broader than originally envisioned or perhaps as broad as that of embryonic stem cells.2MSCs have the ability to differentiate into different mesenchymal lineages,such as osteoblasts,chondrocytes,adipocytes, fi broblasts,and adventitial reticular cells.3Consequently, MSCs can be seen as bona fi de cells for all tissues in which they induce osteoprogenitors and then transform into osteoblasts,which are crucial for the mineralization of the extracellular matrix(ECM)of bone.4–6

The osteogenic differentiation of MSCs is regulated by multiple mechanisms,such as key transcription factors,including runt-related transcription factor 2 and Osterix,2,5,7as well as other hormones.1,8–10In addition, epigenetic regulations have an important role in mammalian biology11–12and regulate tissue-speci fi c gene expression.13–14Recently,DNA methylation,which is an epigenetic regulation,was found to have a pivotal role in stem cell differentiation.15DNA methylation occurs on the fi fth position of cytosine(5mC).16DNA cytosines experience a series of modi fi cations performed by a variety of enzymes,including DNA methyltransferases,17which add a methyl group on the fi fth position of cytosine to form 5mC;TET family dioxygenases(TET1,TET2,and TET3),18–19which then oxidize the methyl group to create 5-hydroxymethylcytosine;20and 5-formylcytosine and 5-carboxyl cytosine,which complete the cycle.21The epigenetic activation of bone-spec i fi c genes mediated by promoter demethylation typically occurs when MSCs differentiate into osteoblasts,22and the inhibition of stem-cell-speci fi c genes by promoter methylation is a crucial epigenetic mechanism during stem cell differentiation.23

Very recently,the methylation of N6-methyladenine (N6-mA)has been reported as another DNA methylationevent,and ALKBH1 was discovered as a demethylase for DNA N6-mA.11,24ALKBH1,a member of the AlkB family,is a 2-oxoglutarate and Fe2+-dependent hydroxylase.25–26ALKBH1 has an important role in epigenetic regulation by accommodating the expression of pluripotency markers and genes related to neural differentiation during embryogenesis.27ALKBH1 is involved in f i ne-tuning the level of a core transcriptional network and regulating the developmental regulatory microRNAs involved in pluripotency and differentiation.21Most of the Alkbh1−/−mice died during embryogenesis,and survivors exhibit tissue developmental defects,including prolonging the expression of pluripotency markers,28and multiple defects in eyes, craniofacial,sternum,and limb skeleton,26which suggests that ALKBH1 is indispensable for stem differentiation and development.However,the role of ALKBH1 and DNA N6-mA in regulating osteogenic differentiation is largely unknown.

In this study,we demonstrated that the depletion or overexpression of ALKBH1 in human MSCs regulates the levels of genomic DNA N6-mA and signi f i cantly affects osteogenic differentiation and bone formation.Mechanically,we found that the depletion of ALKBH1 results in the accumulation of N6-mA on the promoter region of activating transcription factor 4(ATF4),which subsequently silences ATF4 transcription.

MATERIALS AND METHODS

Cell culture

Human bone marrow-derived MSCs were obtained from American Type Culture Collection(ATCC,Manassas,VA, USA).Cells were cultured in Dulbecco’s modi f i ed Eagle’s medium(DMEM)supplemented with 10%fetal bovine serum(Gibco,Carlsbad,CA,USA)plus 100 U·mL-1of penicillin and 100 mg·mL-1of streptomycin(Gibco)at 37°C with a humidi f i ed atmosphere of 5%CO2.To induce osteogenic differentiation,MSCs were seeded in 6-or 24-well plates.After con f l uence,cells were treated with osteogenic medium containing 50 μmol·L-1ascorbic acid, 10 mmol·L-1β-glycerophosphate,and 10 nmol·L-1dexamethasone(Sigma,Shanghai,China).All experimental protocols and procedures were approved by the State Key Laboratory of Oral Diseases,West China Hospital of Stomatology,Sichuan University.

Gene knockdown and overexpression

ALKBH1-targeted and control small interfere RNAs were purchased from Santa Cruz(Dallas,TX,USA).Transfection was performed using Lipofectamine RNAiMAX reagent (Invitrogen)according to the manufacturer's instructions.Knockdown ef f i ciency was determined by reverse transcription-PCR(RT-PCR)and western blot 2 days after the transfection.The lentivirus particles of ALKBH1 and scrambled shRNAs were obtained from Genecopoeia (Guangzhou,China).The stable cell lines were established by puromycin selection.

For ALKBH1 overexpression,lentiviruses expressing the human ALKBH1 gene were purchased from Genecopoeia. MSCs were infected with ALKBH1 or empty vectors in the presence of polybrene(Sigma)for 24 h and were selected with puromycin(Sigma).For ATF4 overexpression,the adenovirus particles expressing human ATF4 or GFP (control)were obtained from Cyagen(Guangzhou,China).

RNA isolation and RT-PCR

Total RNA was isolated using the Trizol reagent(Invitrogen) according to the manufacturer’s instructions.The complementary DNA was prepared from 2 μg aliquots of RNA using a QuantiTec reverse transcription kit(Qiagen,Valencia,CA,USA).29–31Quantitative real-time PCR was performed using SYBR Premix Ex Taq(Takara,Dalian,China)in an ABI7500 real-time PCR system(Applied Biosystems, Foster City,CA,USA).The primer sequences used are listed in Table 1.Relative expression was calculated using a 2-ΔΔCtmethod32by normalization with Gapdh housekeeping gene expression and presented as fold increase relative to control.

Western blot

Cells were lysed in RIPA buffer(Pierce,Rockford,IL,USA) supplemented with a protease inhibitor cocktail(Roche, Mannheim,Germany)and centrifuged at 18 000 g for 15 min at 4°C.The supernatants were heated at 95°C for 5 min in sample buffer containing 2%SDS and 1% 2-mercaptoethanol,separated on 10%SDS–polyacrylamide gels,and transferred to polyvinylidene di f l uoride membranes using a semi-dry transfer apparatus(Bio-Rad).33The membranes were blocked with 5%milk for 1 h and then incubated with anti-ALKBH1(Millipore,Billerica,MA,USA, 1:1 000),anti-ATF4(Abcam,Cambridge,MA,USA,1:1 000) or anti-α-Tubulin(Sigma,1:5 000)overnight followed by a horseradish peroxidase-conjugated anti-rabbit or antimouse IgG(Jackson ImmunoResearch,West Grove,PA, USA).The antibody–antigen complexes were visualized with SuperSignal reagents(Pierce,Rockford,IL,USA).

Dot blot

Genomic DNA was isolated using a PureLink Genomic DNA kit(Invitrogen)and then denatured at 95°C for 10 min in 0.4 mol·L-1NaOH and 10 mmol·L-1EDTA buffer.Samples were spotted on the membrane(Zeta-Probe,Bio-Rad, Hercules,CA,USA)using a Dot-Blot micro f i ltration apparatus(Bio-Rad)and baked at 80°C for 30 min.Membranes were blocked in blocking buffer(5%milk in PBST)for 1 h at room temperature and incubated with N6-mA antibody (202-003,Synaptic Systems,Goettingen,Germany,1:2 000) overnight at 4°C.After three washes,membranes were incubated with horseradish peroxidase-linked secondary anti-rabbit IgG(Jackson ImmunoResearch).The antibody–antigen complexes were visualized with SuperSignal reagents(Pierce).To ensure an equal amount of DNA was spotted,the same membrane was stained with 0.02% methylene blue in 0.3 mol·L-1sodium acetate(pH 5.2).

ALP and Alizarin red staining

For alkaline phosphatase(ALP)staining,cells were grown in osteogenic differentiation medium for 7 days.Cells were then

fi xed in 70%ethanol and incubated with a staining solution of 0.25%naphthol AS-BI phosphate and 0.75%Fast Blue BB dissolved in 0.1 mol·L-1Tris buffer(pH 9.3).We also quanti fi ed the ALP activity using a commercial kit according to the manufacturer’s protocol(Cell Biolab,San Diego,CA,USA).

For mineralization assays,cells were cultured in differentiation medium for 2–3 weeks,f i xed with 70%ethanol, and stained with 40 mmol·L-1Alizarin red S(pH 4.2,Sigma) for 10 min.34Mineralized bone nodules stained with alizarin red were distained with 10%cetylpyridinium chloride in 10 mmol·L-1sodium phosphate(pH 7.0),and the calcium concentration was determined by absorbance measurements at 562 nm.

Ectopic bone formation

Three-month-old immunocompromised beige mice were obtained from the Experimental Animal Center of the University and housed in pathogen-free facilities under a 12-h light and 12-h dark cycle.All procedures were conducted in accordance with The Guidelines for the Care and Use of Laboratory Animals of State Key Laboratory of Oral Diseases,West China Hospital of Stomatology,Sichuan University.Approximately 5×106of cells were mixed with 60 mg of pure phase β-tricalcium phosphate particles(SynthoGraft,Bicon,Boston,MA,USA) and then transplanted subcutaneously under the dorsal surface as described previously.11,24Six weeks after transplantation,the transplants were collected,f i xed with 10% formalin,and decalci f i ed with 10%EDTA.Paraf f i n sections were fabricated and stained with hematoxylin and eosin.35

Chromatin immunoprecipitation assay

The chromatin immunoprecipitation assay was performed using a Simple ChIP Assay kit(Cell Signaling Technology, Danvers,MA,USA)according to the manufacturer’s protocol31with an antibody against N6-mA(cat#202003, Synaptic Systems)or the control normal rabbit IgG(cat#sc-2027,Santa Cruz).After dissociating the DNA–protein complexes,pulled down DNA along with the input DNA(devoid of antibody)were subjected to quantitative PCR analysis with primers to interrogate the ATF4 promoter(Table 1).The results are expressed as the percentage of input DNA.

Statistical analysis

All values were presented as the mean±s.e.Two-tailed Student’s t-test and one-way analysis of variance followed by the Tukey’s test were used for single and multiple comparisons with assess the statistical inference on difference among each pair of data sets,respectively. A P value＜0.05 was considered statistically signi f i cant.

RESULTS

ALKBH1 is upregulated during osteogenic differentiation We f i rst evaluated the expression pro f i le of ALKBH1 in human MSCs during osteogenic differentiation.As determined by real-time RT-PCR,the ALKBH1 messenger RNA levels were signi f i cantly upregulated in response to osteogenic induction(Figure 1a).This observation was also con f i rmed by western blot analysis(Figure 1b).These results suggest that ALKBH1 may have a role in the osteogenic differentiation of MSCs.

Depletion of ALKBH1 inhibits osteogenic differentiation in vitro

To investigate the role of ALKBH1 in osteogenic differentiation,we knocked down ALKBH1 in human MSCs.The knockdown ef f i ciency was con f i rmed by RT-PCR and western blot(Figure 2a and b).Given that ALKBH1 was recently discovered as a demethylase for DNA N6-mA,we evaluated the modi f i cation of N6-mA using a DNA dot blot assay.As shown in Figure 2c,depletion of ALKBH1 markedly increased N6-mA levels in whole genomic DNA of MSCs. After osteogenic induction for 7 days,we found that the small interfere RNA-mediated depletion of ALKBH1signi f i cantly reduced ALP activity,which is an early marker of osteoblastic differentiation(Figure 2d and e). We also assessed ECM mineralization by Alizarin red S staining.As shown in Figure 2f and g,the mineralization was signi f i cantly decreased after ALKBH1 depletion.In addition, the knockdown of ALKBH1 inhibited the expression of osteogenic-related genes,such as RUNX2,Osterix(SP7), and Osteocalcin(GBLAP)(Figure 2h–j).

Depletion of ALKBH1 inhibits bone formation in vivo

To verify our in vitro f i ndings,we examined whether the knockdown of ALKBH1 affected MSC-mediated bone formation in vivo.To this end,we generated the stable knockdown MSCs using lentiviruses expressing shRNA and implanted them with β-TCP carriers into immunocompromised mice subcutaneously.RT-PCR and western blot analysis showed that＞85%of the ALKBH1 was depleted in MSCs expressing ALKBH1 shRNA(shALKBH1)compared with those expressing scrambled shRNA(shScram).The N6-mA levels in whole genomic DNA were increased.Notably,hematoxylin and eosin staining showed that ALKBH1-depleted cells formed less bone tissues(Figure 3d)than did the shScram cells.Quantitative measurement of mineralized tissue areas revealed a＞40%decrease in bone formation(Figure 3e).

Overexpression of ALKBH1 enhances osteoblastic

differentiation of MSCs

To investigate the effects of ectopic overexpression of ALKBH1on osteoblastic differentiation,human MSCs were stably transduced with lentiviruses expressing ALKBH1 (Figure 4a and b).As expected,ALKBH1 overexpression decreased the N6-mA levels in whole genomic DNA (Figure 4c).In addition,ALP activity and cell mineralization of MSCs were enhanced by the overexpression of ALKBH1 (Figure 4d–g).RT-PCR showed that the expression of osteogenic-related genes,such as RUNX2,SP7,and GBLAP, was signi f i cantly elevated after osteogenic induction for 7 days(Figure 4h–j).

Depletion of ALKBH1 impairs ATF4 transcription

ATF4 is a transcription factor that has a pivotal role in osteogenesis along with RUNX2 and Osterix.Interestingly, we found that the depletion of ALKBH1 in MSCs signi f i cantly reduced the ATF4 messenger RNA and protein levels after osteogenic reduction for 7 days(Figure 5a and b). More importantly,chromatin immunoprecipitation assays demonstrated that ALKBH1 binds to the promoter region of ATF4(Figure 5c).Knockdown of ALKBH1 restricted this binding(Figure 5c)and increased the abundance of N6-mA on the promoter(Figure 5d),which led to transcription silencing.These f i ndings indicated that ALKBH1 may regulate the osteoblastic differentiation of MSCs by removing the N6-mA modi f i cations on ATF4.

ATF4 overexpression rescues the phenotypes

To further elucidate the mechanism,we performed rescue experiments by overexpressing ATF4 or control GFP in stable ALKBH1-depleted MSCs using adenoviruses.The successful transduction was con f i rmed by RT-PCR and western blot (Figure 6a and b).Ectopic ATF4 expression signi f i cantly increased the expression of SP7,a master transcription factor for osteogenic differentiation(Figure 6c).In addition,ALP activity and mineralization were rescued(shALKBh1 +Ad-ATF4 vs shALKBh1+Ad-GFP;Figure 6d–f).

DISCUSSION

MSCs have garnered attention owing to their potential for osteogenic differentiation and regeneration therapy.36–38Exploring the mechanism of MSC lineage speci f i cation and differentiation offers a brand-new perspective for clinical applications.39In the present study,we found that the expression of ALKBH1 is upregulated during osteogenic differentiation in vivo.The depletion of ALKBH1 markedly increased the N6-mA levels and signi f i cantly reduced the expression of osteogenic-related genes,ALP activity,and ECM mineralization.By contrast,the ectopic overexpression of ALKBH1 enhanced the osteoblastic differentiation of MSCs.Mechanically,we found that ALKBH1 may regulate osteoblastic differentiation by removing N6-mA modi f i cations on ATF4.

Previous studies have shown that ALKBH1,which was identi f i ed as a DNA demethylase for N6-mA in Embryonic stem cells,has a crucial function in early development by regulating genes that are involved in differentiation and pluripotency.25–26In our study,ALKBH1 depletion inhibits bone formation both in vivo and in vitro.We further noticed an increase in N6-mA and reduction in osteogenic-related genes and indexes.Ougland et al.reported that ALKBH1 interacts with several core transcriptional factors,such as OCT4,SOX2,and NANOG,to maintain the pluripotency of Embryonic stem cell.25,40–41Moreover,ALKBH1 may regulate microRNAs that are associated with the differentiation of neuronal cells.21In contrast,mice lacking ALKBH1 display defects of small or missing eyes,especially in the right eye,and multiple defects in the craniofacial,sternum, and limb skeleton.26Together with the f i ndings on ALKBH1 by Nordstrand et al.,these data indicate that Alkbh1−/−mice exhibited an incomplete condensation of mesenchymal cells during ossi f i cation,which is consistent with our hypothesis.

Recently,ALKBH1 was discovered as a demethylase for DNA N6-mA,thus offering a new perspective for DNA methylation.However,there is wide acceptance that the DNA methylation always occurs on the C5 position of cytosine residues in CpG sites in DNA.20,42Fu et al.22demonstrated that epigenetic activation of bone-speci f i c genes mediated by promoter demethylation typically occurs when MSCs differentiate into osteoblasts.Moreover, Dansranjavin et al.23suggested that the inhibition of stem-cell-speci f i c genes by promoter methylation is a crucial epigenetic mechanism during stem cell differentiation.In previous studies,Wu et al.demonstrated that an increase of N6-mA in Alkbh1−/−cells leads to genesilencing and that most of these genes are developmental factors and lineage-specifying genes.11Intriguingly,these genes are most markedly enriched on the X chromosome and Chr13,indicating that the increase in N6-mA inhibits the transcription on X chromosome,especially on young full-length LINE-1 transposons(L1 elements).11Taken together,these data indicate that accumulation of N6-mA at L1 elements is related to the inhibition of nearby gene.Thus,N6-mA modi f i cations have a great in f l uence on the activation of differentiation genes.It would be interesting to explore the relationship between ALKBH1 and N6-mA,and the mechanisms that affect osteogenic differentiation and bone formation.Our result indicated an inverse correlation between ALKBH1 and N6-mA.In addition,the depletion of ALKBH1 in vivo leads to less bone tissue and decreased bone formation.However,fewer papers on DNA demethylases have been published compared with RNA demethylases,which needs further exploration.

In this study,we demonstrated that ALKBH1 binds to the promoter region of ATF4.The lack of ALKBH1 restricted this binding and increased N6-mA in this region,which led to transcription silencing.Our outcome suggested that ALKBH1 removes the N6-mA on ATF4 to regulate the osteogenic differentiation of human MSCs.ATF4,an osteoblast-enriched transcriptional factor of the CREB family,is indispensable for the latest phases of osteogenic differentiation,43bone formation,and mineralization of the ECM.44Previous studies have demonstrated that ATF4 promotes differentiation by upregulating the expression of osteoblast-speci f i c genes,such as RANKL,and by promoting the synthesis of type I collagen,which is a main component of the ECM.5,44These two distinct mechanisms are both dependent on the phosphorylation by RSK2.45Taken together,these data suggested that ALKBH1 enhances osteogenic differentiation by interacting with ATF4.

It needs to be noted that our f i ndings are based on the in vitro experiments.Further in vivo studies are expected. Given that Alkbh1−/−in mice leads to embryonic and postnatal lethality,26a tissue-speci f i c mouse model is desired to further elucidate the role of ALKBH1 and DNA N6-mA in regulating osteogenic differentiation.

Collectively,we demonstrated that ALKBH1 enhances osteogenic differentiation by removing the N6-mA modi f ications on ATF4.Our results indicate that N6-mA modi f i cations area mechanism for epigenetic regulation of osteogenic differentiation.

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China(No.81271178 and 81470777).

Competing interests

The authors declare no con f l ict of interest.

1 Nombela-Arrieta C,Ritz J,Silberstein LE.The elusive nature and function of mesenchymal stem cells.Nat Rev Mol Cell Biol 2011;12: 126–131.

2 Deng P,Chen QM,Hong C et al.Histone methyltransferases and demethylases:regulators in balancing osteogenic and adipogenic differentiation of mesenchymal stem cells.Int J Oral Sci 2015;7:197–204.

3 Bianco P,Robey PG,Simmons PJ.Mesenchymal stem cells:revisiting history,concepts,and assays.Cell Stem Cell 2008;2:313–319.

4 Bianco P,Cao X,Frenette PS et al.The meaning,the sense and the signi f i cance:translating the science of mesenchymal stem cells into medicine.Nat Med 2013;19:35–42.

5 Yu S,Zhu K,Lai Y et al.atf4 promotes beta-catenin expression and osteoblastic differentiation of bone marrow mesenchymal stem cells. Int J Biol Sci 2013;9:256–266.

6 Crane JL,Zhao L,Frye JS et al.IGF-1 signaling is essential for differentiation of mesenchymal stem cells for peak bone mass.Bone Res 2013; 1:186–194.

7 Rahman MS,Akhtar N,Jamil HM et al.TGF-beta/BMP signaling and other molecular events:regulation of osteoblastogenesis and bone formation.Bone Res 2015;3:15005.

8 Chiavistelli S,Giustina A,Mazziotti G.Parathyroid hormone pulsatility: physiological and clinical aspects.Bone Res 2015;3:14049.

9 Yuan Q,Sato T,Densmore M et al.Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/-mice.PLoS Genet 2012;8:e1002726.

10 Yuan Q,Sato T,Densmore M et al.FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.J Bone Miner Res 2011;26:2026–2035.

11 Wu TP,Wang T,Seetin MG et al.DNA methylation on N(6)-adenine in mammalian embryonic stem cells.Nature 2016;532:329–333.

12 Guo H,Zhu P,Yan L et al.The DNA methylation landscape of human early embryos.Nature 2014;511:606–610.

13 Bonder MJ,Kasela S,Kals M et al.Genetic and epigenetic regulation of gene expression in fetal and adult human livers.BMC Genomics 2014; 15:860.

14 Wu Y,Zhang S,Yuan Q.N(6)-methyladenosine methyltransferases and demethylases:new regulators of stem cell pluripotency and differentiation.Stem Cells Dev 2016;25:1050–1059.

15 Tsankov AM,Gu H,Akopian V et al.Transcription factor binding dynamics during human ES cell differentiation.Nature 2015;518:344–349.

16 Ye C,Li L.5-hydroxymethylcytosine:a new insight into epigenetics in cancer.Cancer Biol Ther 2014;15:10–15.

17 Ooi SK,O'Donnell AH,Bestor TH.Mammalian cytosine methylation at a glance.J Cell Sci 2009;122:2787–2791.

18 Pastor WA,Aravind L,Rao A.TETonic shift:biological roles of TET proteins in DNA demethylation and transcription.Nat Rev Mol Cell Biol 2013;14:341–356.

19 Hu L,Li Z,Cheng J et al.Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation.Cell 2013;155:1545–1555.

20 Tahiliani M,Koh KP,Shen Y et al.Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009;324:930–935.

21 Hon GC,Song CX,Du T et al.5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation.Mol Cell 2014;56:286–297.

22 Fu G,Ren A,Qiu Y et al.Epigenetic regulation of osteogenic differentiation of mesenchymal stem cells.Curr Stem Cell Res Ther 2016;11: 235–246.

23 Dansranjavin T,Krehl S,Mueller T et al.The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation.Cell Cycle 2009;8:916–924.

24 Greer EL,Blanco MA,Gu L et al.DNA Methylation on N6-Adenine in C.elegans.Cell 2015;161:868–878.

25 Ougland R,Jonson I,Moen MN et al.Role of ALKBH1 in the core transcriptional network of embryonic stem cells.Cell Physiol Biochem 2016;38:173–184.

26 Nordstrand LM,Svärd J,Larsen E et al.Mice lacking Alkbh1 display sexratio distortion and unilateral eye defects.PLoS One 2010;5:e13827.

27 Pan Z,Sikandar S,Witherspoon M et al.Impaired placental trophoblast lineage differentiation in Alkbh1(-/-)mice.Dev Dyn 2008;237:316–327.

28 Ougland R,Lando D,Jonson I et al.ALKBH1 is a histone H2A dioxygenase involved in neural differentiation.Stem Cells 2012;30: 2672–2682.

29 Yuan Q,Jiang Y,Zhao X et al.Increased osteopontin contributes to inhibition of bone mineralization in FGF23-de f i cient mice.J Bone Miner Res 2014;29:693–704.

30 Chen D,Jarrell A,Guo C et al.Dermal beta-catenin activity in response to epidermal Wnt ligands is required for f i broblast proliferation and hair follicle initiation.Development 2012;139:1522–1533.

31 Peng L,Hu Y,Chen D et al.Ubiquitin speci f i c peptidase 21 regulates interleukin-8 expression,stem-cell like property of human renal cell carcinoma.Oncotarget 2016;7:42007–42016.

32 Budnick I,Hamburg-Shields E,Chen D et al.De f i ning the identity of mouse embryonic dermal f i broblasts.Genesis 2016;54:415–430.

33 Pei M,Chen D,Li J et al.Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy.Differentiation 2009; 78:260–268.

34 Zou H,Zhao X,Sun N et al.Effect of chronic kidney disease on the healing of titanium implants.Bone 2013;56:410–415.

35 Liang Y,Zhu F,Zhang H et al.Conditional ablation of TGF-beta signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model.Sci Rep 2016;6:29479.

36 Henkel J,Woodruff MA,Epari DR et al.Bone Regeneration Based on Tissue Engineering Conceptions-A 21st Century Perspective.Bone Res 2013;1:216–248.

37 Kim MO,Jung H,Kim SC et al.Electromagnetic f i elds and nanomagnetic particles increase the osteogenic differentiation of human bone marrowderived mesenchymal stem cells.Int J Mol Med 2015;35:153–160.

38 Peng L,Ye L,Zhou XD.Mesenchymal stem cells and tooth engineering. Int J Oral Sci 2009;1:6–12.

39 Lee J,Abdeen AA,Kilian KA.Rewiring mesenchymal stem cell lineage speci f i cation by switching the biophysical microenvironment.Sci Rep 2014;4:5188.

40 Tay Y,Zhang J,Thomson AM et al.MicroRNAs to Nanog,Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008;455:1124–1128.

41 Olariu V,Lovkvist C,Sneppen K.Nanog,Oct4 and Tet1 interplay in establishing pluripotency.Sci Rep 2016;6:25438.

42 Ficz G,Branco MR,Seisenberger S et al.Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011;473:398–402.

43 Elefteriou F,Ahn JD,Takeda S et al.Leptin regulation of bone resorption by the sympathetic nervous system and CART.Nature 2005;434: 514–520.

44 Elefteriou F,Benson MD,Sowa H et al.ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 2006;4:441–451.

45 Yang X,Matsuda K,Bialek P et al.ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology;implication for Cof f i n-Lowry Syndrome.Cell 2004;117:387–398.

This work is licensed under a Creative Commons Attribution 4.0 International License.The images or other third party material in this article are included in the article’s Creative Commons license,unless indicated otherwise in the credit line;if the material is not included under the Creative Commons license,users will need to obtain permission from the license holder to reproduce the material.To view a copy of this license,visit http://creativecommons.org/licenses/by/4.0/

©The Author(s)2016

Research(2016)4,16033;

10.1038/boneres.2016.33;published online:11 October 2016

State Key Laboratory of Oral Diseases,West China Hospital of Stomatology,Sichuan University,Chengdu,China

Correspondence:Shujuan Zou(shujuanzou@aliyun.com)

Received:3 August 2016;Revised:13 August 2016;Accepted:14 August 2016